Form D · Pharmaceuticals
ASCALON INTERNATIONAL, INC.
Scottsdale, AZ · CIK 0001489213
Offering snapshot reported Dec 8, 2011 · SEC filing
- Reported sold
- $100K Offering amount: $100K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Nov 23, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 8, 2011 | Initial | $100,000 | No comparison | 2 | SEC filing |
| May 6, 2010 | Initial | $805,300 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-169793
Source: Form D, filed Dec 8, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Grant Bogle | Director |
| Lloyd Everson | Director |
| Edward Jacobs | Director, Executive |
| Mark Lewis | Executive |
| Richard Love | Director |
| Robert Sobol | Director, Executive |
| Eric Tooker | Director, Executive |
| Daniel Von Hoff | Director, Executive |
| Jennifer Webster | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
9977 North 90 Th Street Suite 110
Scottsdale, AZ, 85258
Scottsdale, AZ, 85258